DOROTA M MALINOWSKI
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism SHAVANO PARK, TX NPI 1194747253
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism TX Novo Nordisk AS All categories
General Payments — all program years on this page
$19,971.53
- Category: General Payments
- Program years: PY2018–2024
- Record count: 1,122
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,794.04 across 78 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,794.04 | 78 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $254.95 | 14 |
| SANOFI-AVENTIS U.S. LLC | $218.33 | 16 |
| DEXCOM, INC. | $169.65 | 8 |
| Lilly USA, LLC | $147.22 | 8 |
| BETA BIONICS, INC. | $145.84 | 1 |
| Alexion Pharmaceuticals, Inc. | $129.91 | 1 |
| Tandem Diabetes Care, Inc. | $125.00 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $86.83 | 5 |
| Ascensia Diabetes Care US Inc. | $85.52 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $75.92 | 4 |
| SHIELD THERAPEUTICS INC | $75.58 | 5 |
| CeQur Corporation | $63.89 | 1 |
| ABBVIE INC. | $56.08 | 4 |
| Abbott Laboratories | $39.38 | 2 |
| Amgen Inc. | $34.98 | 2 |
| Averitas Pharma Inc. | $22.14 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.94 | 1 |
| Kyowa Kirin, Inc. | $15.66 | 1 |
| Insulet Corporation | $15.21 | 1 |
| Radius Health, Inc. | $14.01 | 1 |
By program year
Records — PY2024 (78)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.